Last Updated: November 8, 2026

ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE Drug Patent Profile

« Back to Dashboard


When do Acetaminophen, Caffeine, And Dihydrocodeine Bitartrate patents expire, and when can generic versions of Acetaminophen, Caffeine, And Dihydrocodeine Bitartrate launch?

Acetaminophen, Caffeine, And Dihydrocodeine Bitartrate is a drug marketed by Mikart, Wraser Pharms Llc, Boca Pharma Llc, and West-ward Pharm Corp. and is included in five NDAs.

The generic ingredient in ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE?
  • What are the global sales for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE?
  • What is Average Wholesale Price for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE?
Summary for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
US Patents:0
Applicants:4
NDAs:5
Raw Ingredient (Bulk) Api Vendors: 3
Patent Applications: 13
DailyMed Link:ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE at DailyMed
Drug patent expirations by year for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE

US Patents and Regulatory Information for ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate CAPSULE;ORAL 040109-001 Aug 26, 1997 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mikart ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate TABLET;ORAL 040316-001 Apr 28, 1999 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Wraser Pharms Llc ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate CAPSULE;ORAL 040688-001 Apr 3, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Boca Pharma Llc ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate TABLET;ORAL 040701-001 Apr 3, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
West-ward Pharm Corp ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate TABLET;ORAL 040637-001 Sep 22, 2006 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links